A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection

ABSTRACT Variants near the HLA-DP gene show the strongest genome-wide association with chronic hepatitis B virus (HBV) infection and HBV recovery/persistence in Asians. To test the effect of the HLA-DP region on outcomes to HBV infection, we sequenced the polymorphic HLA-DPB1 and DPA1 coding exons and the corresponding 3′ untranslated regions (3′UTRs) in 662 individuals of European-American and African-American ancestry. The genome-wide association study (GWAS) variant (rs9277535; 550A/G) in the 3′UTR of the HLA-DPB1 gene that associated most significantly with chronic hepatitis B and outcomes to HBV infection in Asians had a marginal effect on HBV recovery in our European- and African-American samples (odds ratio [OR] = 0.39, P = 0.01, combined ethnic groups). However, we identified a novel variant in the HLA-DPB1 3′UTR region, 496A/G (rs9277534), which associated very significantly with HBV recovery in both European and African-American populations (OR = 0.37, P = 0.0001, combined ethnic groups). The 496A/G variant distinguishes the most protective HLA-DPB1 allele (DPB1*04:01) from the most susceptible (DPB1*01:01), whereas 550A/G does not. 496A/G has a stronger effect than any individual HLA-DPB1 or DPA1 allele and any other HLA alleles that showed an association with HBV recovery in our European-American cohort. The 496GG genotype, which confers recessive susceptibility to HBV persistence, also associates in a recessive manner with significantly higher levels of HLA-DP surface protein and transcript level expression in healthy donors, suggesting that differences in expression of HLA-DP may increase the risk of persistent HBV infection.

[1]  Bjoern Peters,et al.  Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity , 2010, The Journal of Immunology.

[2]  D. Ge,et al.  HLA-C cell surface expression and control of HIV / AIDS correlate with a variant upstream of HLA-C , 2009 .

[3]  W. Tan,et al.  Strong influence of human leukocyte antigen (HLA)‐DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population , 2011, Hepatology.

[4]  R. Apps,et al.  Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti‐HLA antibodies , 2009, Immunology.

[5]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[6]  J. Goedert,et al.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. , 1989, The New England journal of medicine.

[7]  D. Jones,et al.  Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. , 1986, Journal of immunology.

[8]  J. Goedert,et al.  Comprehensive Analysis of Class I and Class II HLA Antigens and Chronic Hepatitis B Virus Infection , 2003, Journal of Virology.

[9]  F. Brodsky,et al.  Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. , 1987, Human immunology.

[10]  S M McKinlay,et al.  Hemophilia growth and development study. Design, methods, and entry data. , 1993, The American journal of pediatric hematology/oncology.

[11]  F. Rodríguez-Frías,et al.  [Molecular virology of the hepatitis B virus]. , 2008, Enfermedades infecciosas y microbiologia clinica.

[12]  E. Schadt,et al.  Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver , 2011, Genes and Immunity.

[13]  rashmi singh,et al.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations. , 2007, World journal of gastroenterology.

[14]  N. Afdhal.  The natural history of hepatitis C. , 2004, Seminars in liver disease.

[15]  F. Pereyra,et al.  Differential microRNA regulation of HLA-C expression and its association with HIV control , 2011, Nature.

[16]  J. Sedlák,et al.  Characterization of a new murine monoclonal antibody against human DP antigens. , 1988, Tissue antigens.

[17]  J. Margolick,et al.  Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. , 1998, JAMA.

[18]  M. Carrington,et al.  Class II HLA alleles and hepatitis B virus persistence in African Americans. , 1999, The Journal of infectious diseases.

[19]  P. Gregersen,et al.  Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. , 1988, Journal of immunology.

[20]  N. Amodei,et al.  Hemophilia Growth and Development Study: caregiver report of youth and family adjustment to HIV disease and immunologic compromise. , 2003, Journal of pediatric psychology.

[21]  Anbupalam Thalamuthu,et al.  A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. , 2011, Human molecular genetics.

[22]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[23]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[24]  K. Hyams.  Risks of chronicity following acute hepatitis B virus infection: a review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Y. Kamatani,et al.  A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. , 2011, Human molecular genetics.

[26]  Robert M. Plenge,et al.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis , 2011, Nature Genetics.

[27]  J. Bijlsma,et al.  Th2 mediated regulation in RA and the spondyloarthropathies , 2002, Annals of the rheumatic diseases.

[28]  J. Goedert,et al.  Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32: Evidence that CCR5 Contributes to Viral Persistence , 2006, Journal of Virology.

[29]  J. Phair,et al.  Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. , 1992, Journal of acquired immune deficiency syndromes.

[30]  F. Bach,et al.  Detection of a novel human class II HLA antigen , 1983, Nature.

[31]  S. Khakoo,et al.  Understanding the host genetics of chronic hepatitis B and C. , 2011, Seminars in liver disease.

[32]  J. Goedert,et al.  Interaction between RANTES Promoter Variant and CCR5Δ32 Favors Recovery from Hepatitis B1 , 2008, Journal of Immunology.

[33]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.